Efficacy and safety of a bortezomib and reduced intensity cytarabine based protocol, TMC ALLR1, for relapsed childhood ALL in India

The feasibility of bortezomib (BZB) in induction and reduced cytarabine doses in intensification was evaluated in children with relapsed acute lymphoblastic leukaemia (rALL) at a single centre in India. Of 55 children with rALL 23 received supportive care and 7 refused treatment, with a median survi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Haematol
Autori principali: Roy, Prakriti, Islam, Rubina, Saha, Debparna, Gogoi, Manash, Mishra, Deepak Kumar, Arora, Neeraj, Parihar, Mayur, Krishnan, Shekhar, Saha, Vaskar
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785345/
https://ncbi.nlm.nih.gov/pubmed/31168836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi